Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31127692)

  • 1. Molecular characterization of colorectal cancer using whole-exome sequencing in a Taiwanese population.
    Chang YS; Lee CC; Ke TW; Chang CM; Chao DS; Huang HY; Chang JG
    Cancer Med; 2019 Jul; 8(8):3738-3747. PubMed ID: 31127692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted exome sequencing reveals distinct pathogenic variants in Iranians with colorectal cancer.
    Ashktorab H; Mokarram P; Azimi H; Olumi H; Varma S; Nickerson ML; Brim H
    Oncotarget; 2017 Jan; 8(5):7852-7866. PubMed ID: 28002797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pathway-centric survey of somatic mutations in Chinese patients with colorectal carcinomas.
    Ling C; Wang L; Wang Z; Xu L; Sun L; Yang H; Li WD; Wang K
    PLoS One; 2015; 10(1):e0116753. PubMed ID: 25617745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spatio-temporal mutation profiles of case-matched colorectal carcinomas and their metastases reveal unique de novo mutations in metachronous lung metastases by targeted next generation sequencing.
    Kovaleva V; Geissler AL; Lutz L; Fritsch R; Makowiec F; Wiesemann S; Hopt UT; Passlick B; Werner M; Lassmann S
    Mol Cancer; 2016 Oct; 15(1):63. PubMed ID: 27756406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational profile evaluates metastatic capacity of Chinese colorectal cancer patients, revealed by whole-exome sequencing.
    Yang Y; Chen J; Peng H; Xiao Z; Xu W; Zheng M; Li Z; Cao P
    Genomics; 2024 May; 116(3):110809. PubMed ID: 38492821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between mutations of critical pathway genes and survival outcomes according to the tumor location in colorectal cancer.
    Lee DW; Han SW; Cha Y; Bae JM; Kim HP; Lyu J; Han H; Kim H; Jang H; Bang D; Huh I; Park T; Won JK; Jeong SY; Park KJ; Kang GH; Kim TY
    Cancer; 2017 Sep; 123(18):3513-3523. PubMed ID: 28513830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi gene mutation signatures in colorectal cancer patients: predict for the diagnosis, pathological classification, staging and prognosis.
    Zhuang Y; Wang H; Jiang D; Li Y; Feng L; Tian C; Pu M; Wang X; Zhang J; Hu Y; Liu P
    BMC Cancer; 2021 Apr; 21(1):380. PubMed ID: 33836681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation analysis of 13 driver genes of colorectal cancer-related pathways in Taiwanese patients.
    Chang YC; Chang JG; Liu TC; Lin CY; Yang SF; Ho CM; Chen WT; Chang YS
    World J Gastroenterol; 2016 Feb; 22(7):2314-25. PubMed ID: 26900293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing the landscape of colorectal cancer using targeted deep sequencing.
    Lee CS; Song IH; Lee A; Kang J; Lee YS; Lee IK; Song YS; Lee SH
    Sci Rep; 2021 Apr; 11(1):8154. PubMed ID: 33854094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of Next-Generation Sequencing for the Detection of Microsatellite Instability in Colorectal Cancer With Deficient DNA Mismatch Repair.
    Ratovomanana T; Cohen R; Svrcek M; Renaud F; Cervera P; Siret A; Letourneur Q; Buhard O; Bourgoin P; Guillerm E; Dorard C; Nicolle R; Ayadi M; Touat M; Bielle F; Sanson M; Le Rouzic P; Buisine MP; Piessen G; Collura A; Fléjou JF; de Reyniès A; Coulet F; Ghiringhelli F; André T; Jonchère V; Duval A
    Gastroenterology; 2021 Sep; 161(3):814-826.e7. PubMed ID: 33992635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Driver genes exome sequencing reveals distinct variants in African Americans with colorectal neoplasia.
    Ashktorab H; Azimi H; Varma S; Lee EL; Laiyemo AO; Nickerson ML; Brim H
    Oncotarget; 2019 Apr; 10(27):2607-2624. PubMed ID: 31080553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The differentially mutational spectra of the APC, K-ras, and p53 genes in sporadic colorectal cancers from Taiwanese patients.
    Wang JY; Hsieh JS; Lu CY; Yu FJ; Wu JY; Chen FM; Huang CJ; Lin SR
    Hepatogastroenterology; 2007 Dec; 54(80):2259-65. PubMed ID: 18265644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analysis of oncogenic fusions in mismatch repair deficient colorectal carcinomas by sequential DNA and RNA next generation sequencing.
    Wang J; Li R; Li J; Yi Y; Liu X; Chen J; Zhang H; Lu J; Li C; Wu H; Liang Z
    J Transl Med; 2021 Oct; 19(1):433. PubMed ID: 34657620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of Aberrant Alteration of Genome in Colorectal Cancer by Exome Sequencing.
    Liang Y; Jiang L; Zhong X; Hochwald SN; Wang Y; Huang L; Nie Q; Huang H; Xu JF
    Am J Med Sci; 2019 Nov; 358(5):340-349. PubMed ID: 31445671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathogenomic analysis of mismatch repair proficient colorectal adenocarcinoma uncovers novel prognostic subgroups with differing patterns of genetic evolution.
    Braxton DR; Zhang R; Morrissette JD; Loaiza-Bonilla A; Furth EE
    Int J Cancer; 2016 Oct; 139(7):1546-56. PubMed ID: 27194209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic landscape of colorectal cancer in Japan: clinical implications of comprehensive genomic sequencing for precision medicine.
    Nagahashi M; Wakai T; Shimada Y; Ichikawa H; Kameyama H; Kobayashi T; Sakata J; Yagi R; Sato N; Kitagawa Y; Uetake H; Yoshida K; Oki E; Kudo SE; Izutsu H; Kodama K; Nakada M; Tse J; Russell M; Heyer J; Powers W; Sun R; Ring JE; Takabe K; Protopopov A; Ling Y; Okuda S; Lyle S
    Genome Med; 2016 Dec; 8(1):136. PubMed ID: 28007036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and coexistence of KRAS, BRAF, PIK3CA, NRAS, TP53, and APC mutations in Indian colorectal cancer patients: Next-generation sequencing-based cohort study.
    Jauhri M; Bhatnagar A; Gupta S; Bp M; Minhas S; Shokeen Y; Aggarwal S
    Tumour Biol; 2017 Feb; 39(2):1010428317692265. PubMed ID: 28222664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole Exome Sequencing of Ulcerative Colitis-associated Colorectal Cancer Based on Novel Somatic Mutations Identified in Chinese Patients.
    Yan P; Wang Y; Meng X; Yang H; Liu Z; Qian J; Zhou W; Li J
    Inflamm Bowel Dis; 2019 Jul; 25(8):1293-1301. PubMed ID: 30794281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New genetic variations discovered in KRAS wild-type cetuximab resistant chinese colorectal cancer patients.
    Jing C; Wang T; Ma R; Cao H; Wang Z; Liu S; Chen D; Zhang J; Wu Y; Zhang Y; Wu J; Feng J
    Mol Carcinog; 2020 May; 59(5):478-491. PubMed ID: 32141150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic Sequencing and Insight into Clinical Heterogeneity and Prognostic Pathway Genes in Patients with Metastatic Colorectal Cancer.
    Kawaguchi Y; Kopetz S; Kwong L; Xiao L; Morris JS; Tran Cao HS; Tzeng CD; Chun YS; Lee JE; Vauthey JN
    J Am Coll Surg; 2021 Aug; 233(2):272-284.e13. PubMed ID: 34111531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.